Maximum quantity allowed is 999
CAS RN: 129618-40-2 | Product Number: N0922
Nevirapine
Purity: >98.0%(GC)
- 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
200MG |
₹10,500.00
|
Contact Us | ≥60 |
|
1G |
₹23,100.00
|
Contact Us | 2 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | N0922 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__1__5H__1__4N__4O = 266.30 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 129618-40-2 |
Reaxys Registry Number | 4757598 |
PubChem Substance ID | 160871291 |
Merck Index (14) | 6490 |
MDL Number | MFCD00866928 |
Appearance | White to Light yellow powder to crystal |
Purity(GC) | min. 98.0 % |
Purity(Nonaqueous Titration) | min. 97.0 % |
Melting point | 244.0 to 248.0 °C |
Melting Point | 246 °C |
Solubility in water | Insoluble |
Degree of solubility in water | < 0.1 g/l |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
RTECS# | JM5562500 |
References
- Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor
- Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor
- Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors
- Nevirapine: a review of its development, pharmacological profile and potential for clinical use
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.